HomeATXS • NASDAQ
add
Astria Therapeutics Inc
Previous close
$13.12
Day range
$12.84 - $13.18
Year range
$3.56 - $13.29
Market cap
738.11M USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 706.00K | — |
Operating expense | 34.81M | 19.98% |
Net income | -31.64M | -28.98% |
Net profit margin | -4.48K | — |
Earnings per share | -0.55 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 227.72M | -33.86% |
Total assets | 271.87M | -24.82% |
Total liabilities | 38.61M | 93.21% |
Total equity | 233.25M | — |
Shares outstanding | 57.08M | — |
Price to book | 5.38 | — |
Return on assets | -30.79% | — |
Return on capital | -33.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -31.64M | -28.98% |
Cash from operations | -32.30M | -15.48% |
Cash from investing | 52.25M | 744.42% |
Cash from financing | 3.00K | -99.98% |
Net change in cash | 19.96M | 408.23% |
Free cash flow | -32.26M | -38.33% |
About
Founded
2008
Headquarters
Website
Employees
78
